摘要
肺癌是全球发病率和死亡率最高的癌症之一,具有起病隐匿和进展迅速的特点,多数患者在确诊时已为晚期,且放化疗效果往往较为局限。“带瘤生存”理论认为痰瘀固结以至根深蒂固是肺癌晚期肿瘤难以消除的主要原因,而寒热错杂以至阴阳离决是肺癌晚期患者死亡的直接原因。因此,“带瘤生存”的治疗策略主张以平调寒热为根本治法,旨在调和阴阳、恢复正气,先存一息以续命;同时少佐祛痰化瘀之品,以冀抑制痰瘀增进,减轻肺癌晚期的肿瘤负荷。虽不能使肺癌肿瘤完全消除,但可使患者与肿瘤得以和平共存,以提高肺癌晚期患者的生存质量和预期寿命,此即中医理论的“带瘤生存”之法,具有一定的理论意义和临床价值。
Lung cancer is one of the highest cancer incidence rate and death rate in the world.The characteristics of the disease are hidden and rapid.Most patients are advanced in the diagnosis,and the effect of radiotherapy and chemotherapy is often limited.The theory of"survival with tumor"holds that the consolidation and deep-rooted of phlegm and blood stasis is the main reason for the difficult elimination of advanced lung cancer,and the mixed cold and heat and the separation of Yin and Yang are the direct cause of death of patients with advanced lung cancer.Therefore,the treatment strategy of"survival with tumor"advocates the fundamental treatment of calming cold and heat,aiming at harmonizing Yin and Yang,restoring healthy Qi,and saving a breath to prolong life;At the same time,the product of eliminating phlegm and removing blood stasis is less used in order to inhibit the promotion of phlegm and blood stasis and reduce the tumor load of advanced lung cancer.Although it can not completely eliminate the tumor of lung cancer,it can make the patient and tumor coexist peacefully,so as to improve the quality of life and life expectancy of patients with advanced lung cancer.This is the"survival with tumor"method of traditional Chinese medicine theory,which has certain theoretical significance and clinical value.
作者
万何琴
袁苏云
雷书浚
曹建雄
Wan Heqin;Yuan Suyun;Lei Shujun;Cao Jianxiong(The First Hospital Affiliated to Hunan University of Chinese Medicine,Changsha 41ooo7,China)
出处
《亚太传统医药》
2023年第5期223-226,共4页
Asia-Pacific Traditional Medicine
基金
湖南省重点研发计划(2018SK2127)
湖南省中医药科研计划(201946)。
关键词
寒热错杂
痰瘀固结
肺癌晚期
带瘤生存
Mixed Cold and Heat
Phlegm and Blood Stasis Consolidation
Advanced Lung Cancer
Tumor Bearing Survival
